Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health (Subscription required) Adrienne Rivlin Read more
Published Articles Life Sciences & Pharma Biopharma predictions for 2026: thoughts from LEK Consulting’s Simon Middleton January 14, 2026
Executive Insights Life Sciences & Pharma From Discovery to Launch: Building Next-Generation Investment Governance for Biotech January 13, 2026
Executive Insights Life Sciences & Pharma From Bench to Bedside: Academic-to-Industry Translation in European Biopharma June 25, 2025
Executive Insights Life Sciences & Pharma When Is It Too Late? Drivers of Commercial Performance for Late Entrants in Biopharma April 28, 2025
Executive Insights Life Sciences & Pharma Launching Novel CDx for Oncology: 7 Strategies for Biopharma Companies April 17, 2025
Case Study Life Sciences & Pharma Building Resilience in a Commercial-Stage Pharma Company’s Supply Chain April 16, 2025
